跳至主要内容
临床试验/CTIS2022-502239-20-00
CTIS2022-502239-20-00招募中1 期

Cluster and Registry trials Of the Working group of heart failure in Denmark - Are SPironolactone and Eplerenone Comparable Treatments? (CROWD-ASPECT)

Bispebjerg Hospital0 个研究点目标入组 7,200 人开始时间: 2022年11月9日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
入组人数
7,200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

年龄范围
18 至 65+(—)
性别
All

入选标准

  • Patients who are registered in the Danish Heart Failure Registry with reduced ejection fraction who have claimed at least one prescription for an aldosterone antagonist

排除标准

  • Patients who had filled in a prescription for an aldosterone antagonist before the date of first registered visit in the Danish Heart Failure Registry and patients who have opted out of the study

研究者

相似试验